FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046928 [Registered on: 31/10/2022] Trial Registered Prospectively
Last Modified On: 29/10/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani
Other (Specify) [Dry Cupping]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical evaluation of effects of Hijama- Bila- Shurt (Dry Cupping) as a part of multimodal approach in the management of fibromyalgia. 
Scientific Title of Study   Clinical evaluation of effects of Hijama- Bila- Shurt (Dry Cupping) as a part of multimodal approach in the management of fibromyalgia. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SUMAYYA PARVEZ 
Designation  PG Scholar 
Affiliation  Department of Ilaj bit tadbeer Ajmal khan Tibbiya college Aligarh Muslim University Aligarh 
Address  Department Of Ilaj bit Tadbeer,Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001
Department Of Ilaj bit Tadbeer, Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001
Aligarh
UTTAR PRADESH
202001
India 
Phone  8273388467  
Fax    
Email  parvezsumayya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  ProfMohd Anwar 
Designation  Professor 
Affiliation  Department of Ilaj bit tadbeer Ajmal khan Tibbiya college Aligarh Muslim University Aligarh 
Address  Department Of Ilaj bit Tadbeer,Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001
Department Of Ilaj bit Tadbeer, Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001
Aligarh
UTTAR PRADESH
202001
India 
Phone  8979224254  
Fax    
Email  mohdanwarnium@gmail.com  
 
Details of Contact Person
Public Query
 
Name  SUMAYYA PARVEZ 
Designation  PG Scholar 
Affiliation  Department of Ilaj bit tadbeer Ajmal khan Tibbiya college Aligarh Muslim University Aligarh 
Address  Department Of Ilaj bit Tadbeer,Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001
Department Of Ilaj bit Tadbeer, Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001
Aligarh
UTTAR PRADESH
202001
India 
Phone  8273388467  
Fax    
Email  parvezsumayya@gmail.com  
 
Source of Monetary or Material Support  
Department Of Ilaj bit Tadbeer,Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 
 
Primary Sponsor  
Name  Ajmal Khan Tibbiya College 
Address  Department Of Ilaj bit Tadbeer,Ajmal Khan Tibbiya College Aligarh Muslim University Aligarh 202001 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sumayya Parvez  Ajmal Khan Tibbiya College  Department of Ilaj Bit Tadbeer AKTC AMU Aligarh
Aligarh
UTTAR PRADESH 
8273388467

parvezsumayya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M797||Fibromyalgia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Amitryptiline 10 mg and Habbe Asgandh  Amitriptiline is used to treat Psychosomatic conditions and Habbe asgandh is used as an analgesic,anti inflammatory,anti depressant,anxiolytic agent. 
Intervention  Dry cupping and Habbe Asgandh  Intervention group A: • Application of Dry Cupping (Hijamah Bila Shurt) once in a week on tender points for 10 minutes for total of 4 weeks. Intervention group B: • Application of Dry Cupping (Hijamah –Bila- Shurt) once in a week on tender points for 10 minutes for total of 4 weeks and Patients will be asked to take 2 tablets (650 mg each) of Habb-e- Asgandh orally twice daily an hour after meals for four weeks.  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Clinically Diagnosed patient of FMS (Based on 2016 revision of American College of Rheumatology (ACR) Diagnostic Criteria of 2011/2010.

2. Patients who are able to give written informed consent and follow the protocol of study.
3. Patients of either sex
4. Patients in age group of 20-60 years.
 
 
ExclusionCriteria 
Details  1. Patients below 20 years and above 60 years

2. Primary generalized osteoarthritis, polymyalgia rheumatica, Rheumatoid arthritis, Diabetic Neuropathy,Hypothyroidism
Pregnant and Lactating women

4. Patients with uncontrolled diabetes and severe hypertension.

5. Patient taking medicine for any other psycho- somatic disorders.
6. History of trauma.
7. Patients having anemia(Hb% less than 9gm%).
8. Patients unable to give informed written consent.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement Criteria- it will be correlated with the subjective and objective parameters.

1.Primary Parameters
• NRS (Numeric Rating Scale)
0-no pain to 10-worst possible pain
 
Every 14th day for 28 days
 
 
Secondary Outcome  
Outcome  TimePoints 
2. Secondary Parameters:
1.Revised Fibromyalgia Impact Questionaire(FIQR)
2.Requirement of acetaminophen(650mg) on weekly basis.

 
Every 14th day for 28 days
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/11/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NA 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Clinical evaluation of  effects of Hijama- Bila- Shurt  (Dry Cupping) as a part of multimodal approach in the management of  fibromyalgia. 
Close